Ballentine Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Buy
1,435
+292
+26% +$137K 0.01% 488
2026
Q1
$453K Sell
1,143
-3
-0.3% -$1.36K 0.01% 565
2025
Q4
$538K Sell
1,146
-661
-37% -$294K 0.01% 477
2025
Q3
$892K Buy
1,807
+523
+41% +$296K 0.01% 351
2025
Q2
$658K Sell
1,284
-45
-3% -$21K 0.01% 405
2025
Q1
$570K Buy
1,329
+475
+56% +$231K 0.01% 409
2024
Q4
$414K Sell
854
-42
-5% -$22K 0.01% 482
2024
Q3
$454K Sell
896
-131
-13% -$70.3K 0.01% 440
2024
Q2
$611K Buy
1,027
+254
+33% +$144K 0.01% 365
2024
Q1
$442K Buy
773
+55
+8% +$30.3K 0.01% 425
2023
Q4
$370K Buy
718
+101
+16% +$51.6K 0.01% 444
2023
Q3
$283K Buy
617
+58
+10% +$26K 0.01% 455
2023
Q2
$243K Buy
+559
New +$225K 0.01% 496

Other funds holding SNPS

Ballentine Partners's SNPS Position: Q2 2026 in Review

Ballentine Partners increased its Synopsys (SNPS) stake by 26% in Q2 2026, buying an estimated $137K and bringing the position to 1,435 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #488.

Ballentine Partners first reported a position in SNPS in Q2 2023 and has held it in 13 quarters since. The position peaked at $892K in Q3 2025. 212 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Ballentine Partners held 1,435 shares of Synopsys worth $640K as of Q2 2026.
  • Ballentine Partners bought 292 Synopsys shares in Q2 2026, an estimated $137K.
  • Synopsys made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #488 holding.
  • Ballentine Partners first reported a position in Synopsys in Q2 2023 and has held it in 13 quarters since.
  • Ballentine Partners's Synopsys position peaked at $892K in Q3 2025.
  • 212 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.